GE HealthCare Unveils Logiq Totus Ultrasound at ECR
Designed for full-body imaging, the new modality reportedly offers a lightweight portable design, AI-powered tools and enhanced high-resolution images.
Emphasizing a combination of workflow enhancements and advances to facilitate improved image quality, GE HealthCare has launched the Logiq Totus ultrasound system at the European Congress of Radiology.
Use of the Logiq Totus ultrasound system enables access to a wide range of transducers to help foster high resolution for a variety of areas, advanced tools such as 2D Shear Wave Elastography and access to cSound™ Architecture, which provides enhanced consistent image quality, according to GE HealthCare.
GE HealthCare said the Logiq Totus ultrasound system, launched at the European Congress of Radiology, offers a combination of workflow enhancements and advances to facilitate improved image quality. (Image courtesy of GE HealthCare.)
The company said other advantages with the lightweight, portable system include tools such as Scan Assistant and Voice Control that help streamline workflows, and access to Breast and Thyroid Assistant artificial intelligence (AI) support tools from Koios Medical.
“ … We’re focused on driving innovation that enables precision care, and the enhanced (Logiq) portfolio allows us to deliver on this promise with products and solutions that help clinicians optimize care with ease and efficiency,” said Jyoti Gera, the general manager of General Imaging and Primary Care, Ultrasound at GE HealthCare.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
